169330 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
Methods and kits for detecting misfolded proteins
#602Method to select animals with a high capacity of embryo production
#603Immunological test for detecting autoantibodies against testicular antigens
#604BIOMARKERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#605IDENTIFYING AND QUANTIFYING BIOMARKERS ASSOCIATED WITH PREECLAMPSIA
#606Secretome Profile-Facilitated In Vitro Fertilization
#607METHODS OF DIAGNOSING AND TREATING COMPLICATIONS OF PREGNANCY
#608Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
#609TOTAL PLASMA FVII/FVIIA LEVELS AS INDICATORS OF PRE-ECLAMPSIA OF PREGNANT FEMALES
#610METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION DURING ASSISTED REPRODUCTION IN A SUBJECT
#611Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#612Methods and Kits for Predicting the Onset of Labour
#613Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
#614Prognostic Marker for Endometrial Carcinoma
#615Marker for inflammatory conditions
#616Method for the detection of endometriosis using an ME-2 antigen
#617Use of the IRAP protein for implementing methods of diagnosis and of prognosis
#618Methods and kits for detecting ITA in a biological sample
#619Detection of intraamniotic infection
#620METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE
#621ANTI-PlGF ANTIBODIES AND METHODS USING SAME
#622Compositions and methods for the identification and use of epigenetic markers useful in the study of normal and abnormal mammalian gametogenesis
#623PRETERM DELIVERY DIAGNOSTIC ASSAY
#624Soluble CD117 () for diagnosis of preeclampsia and eclampsia
#625Method for assessing oocyte maturation
#626METHOD AND KIT FOR DIAGNOSIS OF MALE FERTILITY
#627USE OF A STEROID PROFILE IN OVARIAN FOLLICULAR FLUID FOR DIAGNOSIS, PROGNOSIS AND DETERMINING STRATEGIES FOR TREATMENT
#628COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#629COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#630Prophylactic/therapeutic agents for lifestyle-related diseases
#631Method of quantitative assessment on reproductive effort of black-lip pearl oysters using antibody specific thereto
#632METHODS AND KITS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE AND PREGNANCY-RELATED DISORDERS IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#633COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION IN RECIPIENTS OF ARTIFICAL INSEMINATION
#634METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX
#635Methods for improving fertility and selectivity for desired offspring sex in artificial insemination
#636Detection of risk of pre-eclampsia
#637METHODS AND DEVICES FOR ASSESSING INFERTILITY AND/OR EGG QUALITY
#638Protein involved in ovarian cancer
#639METHOD FOR RISK REDUCTION IN GLYCEMIC CONTROL
#640GONADAL FUNCTION IMPROVING AGENTS
#641Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1
#642NOVEL METHOD FOR DIAGNOSING PREGNANCY-RELATED COMPLICATIONS
#643Method and pharmacological composition for the diagnosis and treatment of male
#644ASSAY TO DETECT A GYNECOLOGICAL CONDITION
#645Contraceptives Based on SP22 and SP22 Antibodies
#646Detection of endometrial secretion markers for assessment of endometriosis
#647METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA
#648Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility
#649Compositions and methods for early pregnancy diagnosis
#650Method of detecting endometriosis in human subjects using SEQ ID No. 9 or an epitope thereof
#651Uses of Sperm Membrane Protein OBF
#652STG Promoter And Its Use As A Marker For Taste And Oocyte Cells
#653Methods and compositions for detecting spermatozoa or semen in a sample
#654Ovulation Cycle Monitoring and Management
#655Devices and methods for detecting amniotic fluid in vaginal secretions
#656Female fertility test
#657Methods for determining the risk of prenatal complications
#658NOVEL DIAGNOSTIC SENSOR FOR RAPID AND REPRODUCIBLE RO52 PROTEIN DOMAIN DETECTION
#659Method for diagnosing an increased risk of preeclampsia by measuring the level of HIF-α
#660IDENTIFICATION OF ECTOPIC PREGNANCIES
#661Marker for inflammatory conditions
#662Method for prenatal diagnosis
#663Netrin-1 compositions and methods of use thereof
#664Compounds and methods of use thereof for assaying lysophospholipase D activity
#665Electronic analyte assaying device
#666Electronic analyte assaying device
#667Diagnosis of preeclampsia
#668Methods for Predicting Trisomy 21 in a Fetus
#669Immunological Method, Test Kit and Device for the Determination of the Analyte Content of a Sample
#670Assay device
#671Assays for preimplantation factor and preimplantation factor peptides
#672Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#673TREATING PRE-ECLEMPSIA AND CARDIOVASCULAR DISEASES
#674METHOD OF DIAGNOSING PRE-ECLAMPSIA
#675BIOMARKERS FOR PREECLAMPSIA
#676ADAM12, a novel marker for abnormal cell function
#677SPERM LIGANDS AND METHODS OF USE
#678Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
#679Methods for detecting fetal cells in the maternal blood
#680METHOD FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN A SUBJECT IN NEED THEREOF
#681METHOD FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN A SUBJECT IN NEED THEREOF
#682Mass spectrometry assay for congenital adrenal hyperplasia
#683Method of Diagnosing Asthenozoospermia
#684MAGE-11 AS A MARKER FOR ENDOMETRIAL RECEPTIVITY TO EMBRYO TRANSPLANTATION AND A MARKER AND THERAPEUTIC TARGET IN CASTRATION-RECURRENT PROSTATE CANCER
#685ASSAY FOR THE DETECTION OF BIOMARKERS ASSOCIATED WITH PREGNANCY RELATED CONDITIONS
#686VARIANTS OF VEGFR AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF PREGNANCY ASSOCIATED MEDICAL CONDITIONS
#687PREGNANCY TESTING METHOD
#688METHOD FOR ANTENATAL ESTIMATION OF RISK OF ANEUPLOIDY
#689Biomarker for the Medicine and the Biology of the Reproduction
#690Diagnosis and treatment of preeclampsia
#691Soluble Human M-CSF Receptor and Uses Thereof
#692Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
#693Method for reducing the risk of spontaneous abortion in a human female subject
#694Labor biomarkers, methods comprising same, and methods targeting same
#695Methods of diagnosing endometriosis in human subjects using the ME-5 polypeptide
#696EMBRYO QUALITY ASSESSMENT BASED ON BLASTOMERE DIVISION AND MOVEMENT
#697Procurement, Isolation, and Cryopreservation of Endometrial/Menstrual Cells
#698Conjugates of photo-activatable dyes
#699Urinary proteomic biomarker patterns in preeclampsia
#700Methods and Kits for Analyzing Genetic Material of a Fetus
#701MULTIPLEXED DIAGNOSTIC TEST FOR PRETERM LABOR
#702APPLICATION OF SURFACE PLASMON RESONANCE TECHNOLOGY TO MATERNAL SERUM SCREENING FOR CONGENITAL BIRTH DEFECTS
#703MAMMALIAN OOCYTE DEVELOPMENT COMPETENCY GRANULOSA MARKERS AND USES THEREOF
#704GESTATIONAL AGE DEPENDENT PROTEOMIC CHANGES OF HUMAN MATERNAL SERUM FOR MONITORING MATERNAL AND FETAL HEALTH
#705MATERNAL SERUM BIOMARKERS FOR DETECTION OF PRE-ECLAMPSIA
#706Methods and kits to detect and monitor ovarian cancer and preeclampsia
#707HEPARAN SULFATE PROTEOGLYCAN COMPOSITION AND USE THEREOF
#708Diagnostic kits to detect SP22 and SP22 antibodies
#709Assay and kit for predicting implantation success in assisted fertilisation
#710Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
#711Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples
#712Methods of Diagnosing and Treating Complications of Pregnancy
#713Method of determining the sex of birds, reptiles and mammals using steroid hormones
#714Methods for the Diagnosis and Treatment of Preeclampsia
#715DIAGNOSTIC METHOD FOR DETERMINING THE SUSCEPTIBILITY TO DELIVERY AND REAGENT KIT FOR USE THEREFOR
#716METHOD FOR DETECTING AND QUANTITATING MULTIPLE SUBCELLULAR COMPONENTS
#717Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover
#718Method of diagnosis of pregnancy-related complications
#719Methods for staining cells for identification and sorting
#720COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#721Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential
#722Marker for inflammatory conditions
#723Multiple Assay Device
#724Methods of Screening for Atherosclerosis
#725DIAGNOSIS OF FETAL ABNORMALITIES USING NUCLEATED RED BLOOD CELLS
#726Determination of sFlt-1:angiogenic factor complex
#727NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS
#728COMPOSITIONS AND METHODS OF MAKING EMBRYONIC STEM CELLS
#729Kits for the diagnosis of pre-eclampsia or eclampsia
#730Imaging agents and methods of imaging NAALADase or PSMA
#731MARKERS FOR PREECLAMPSIA
#732Methods and kits for detecting ITA in a biological sample
#733Sperm-specific cation channel, CATSPER2, and uses therefor
#734Methods for early diagnosing of an increased risk of preeclampsia
#735PIF peptides biologic activities, site of action, and the antibody to detect PIF
#736Method for reducing the likelihood of implantation failure during assisted reproduction in a subject
#737Methods for predicting embryo viability
#738Human FGF-21 gene and gene expression products
#739PREGNANCY-RELATED ENZYME ACTIVITY
#740Compounds and methods of use thereof for assaying lysophospholipase D activity
#741Marker for prolonged rupture of membranes
#742MARKERS FOR PREECLAMPSIA
#743Methods and compositions for detecting spermatozoa or semen in a sample
#744Testing Process
#745Method for reducing the likelihood of spontaneous abortion presenting a sign or symptom of threatened abortion
#746COMPOSITIONS AND METHODS FOR HEALTHY PREGNANCY
#747Method for monitoring tocolytic treatment
#748Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject in need thereof
#749Method of screening placental proteins responsible for pathophysiology of preeclampsia, and marker for early diagnosis and prediction of preeclampsia
#750Method Related to Gestation Periods
#751QUANTIFICATION OF VITELLOGENIN
#752Assays for preimplantation factor and preimplantation factor peptides
#753Diagnostic test for inflammatory endothelial dysfunctions in pregnancies
#754Assays for preimplantation factor and preimplantation factor peptides
#755Assays for preimplantation factor and preimplantation factor peptides
#756Neoepitope detection of disease using protein arrays
#757Assays for preimplantation factor and preimplantation factor peptides
#758Assays for preimplantation factor and preimplantation factor peptides
#759Method for Detecting and Quantitating Multiple-Subcellular Components
#760METHOD FOR DETECTING AND QUANTITATING MULTIPLE-SUBCELLULAR COMPONENTS
#761Non-invasive prenatal genetic diagnosis using transcervical cells
#762Assay
#763Salivary Protease Assays for Identifying Increased Risk of Preterm Delivery Induced by Premature Rupture of Fetal Membranes
#764Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
#765Procurement, isolation and cryopreservation of endometrial/menstrual cells
#766SCREENING FOR GESTATIONAL DISORDERS
#767NALP7-based diagnosis of female reproductive conditions
#768Methods and materials for identifying polymorphic variants, diagnosing susceptibilities, and treating disease
#769Methods of reducing the likelihood of spontaneous abortion
#770Method for identifying a patient at risk of having difficulty in sustaining a pregnancy
#771Diagnostic markers of human female infertility
#772Contraceptives based on SP22 and SP22 antibodies
#773METHODS AND PRODUCTS FOR MODULATION OF REPRODUCTIVE PROCESSES AND FOR DIAGNOSIS, PROGNOSTICATION AND TREATMENT OR RELATED CONDITIONS
#774ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#775Sperm ligands and methods of use
#776Alpha-fetoprotein Immu31 antibodies and fusion proteins
#777Methods of treating pre-eclampsia and eclampsia
#778Method for Determining the Effectiveness of a Treatment for Preeclampsia
#779Protocol for detecting proteins in a culture containing an embryo
#780Contraceptives based on SP22 and SP22 antibodies
#781SELECTION OF CELLS USING BIOMARKERS
#782METHODS AND KITS FOR PREDICTING RISK FOR PRETERM LABOR
#783Uses of Sperm Membrane Protein Obf
#784Markers of pre-term labor
#785Methods for early detection of pregnancy in cows
#786Diagnosis and treatment of endometriosis
#787METHOD TO DIAGNOSE AND INCREASE FERTILITY OF MAMMALIAN SEMEN USING DNASE AS A DIAGNOSTIC MARKER AND THERAPEUTIC AGENT
#788Methods for Assessing Embryo Viability
#789Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
#790Mullerian inhibiting substance levels and ovarian response
#791Quantitative lateral flow assays and devices
#792Human FGF-21 gene and gene expression products
#793Detection and treatment of cancer
#794Forensic Test for Human Semen
#795Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
#796Screen for pre-eclampsia
#797Methods of determining whether a pregnant woman is at risk of developing preeclampsia
#798Detecting and predicting pre-eclampsia
#799ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#800Native analyte as a reference in lateral flow assays
#801Methods and compositions for modulating gamete adhesion
#802Compositions and methods for early pregnancy diagnosis
#803METABOLOMIC DETERMINATION IN ASSISTED REPRODUCTIVE TECHNOLOGY
#804Use of ADAM 12 for diagnosis and therapy of preeclampsia
#805Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
#806Methods for diagnosing and for monitoring the treatment of recurrent spontaneous abortion
#807Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
#808Pregnancy-associated plasma protein-A2 (PAPP-A2)
#809ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#810Human FGF-21 gene and gene expression products
#811Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
#812Methods of detection of MATER protein autoantibodies
#813Semen preservation
#814Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof
#815Marker for inflammatory conditions
#816Kits for Prenatal Testing
#817MATER-protein specific antibodies and methods of use
#818Method for predicting pregnancy-induced hypertension
#819Determination of pregnancy status in ungulate ruminants
#820Protein involved in ovarian cancer
#821Methods of inhibiting secretion of follicle-stimulating hormone and testosterone
#822Compositions and Methods for Making Embryonic Stem Cells
#823Antibodies for identification of murine fragilis extracellular domain and methods for identifying pluripotent cells
#824Anti-metastin antibody and its use
#825Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
#826Devices and methods for detecting amniotic fluid in vaginal secretions
#827Non-invasive assessment of intra-amniotic environment
#828Embryo implantation inhibitor
#829Periostin-based diagnostic assays
#830TEX14 compositions and modulators thereof to alter intercellular bridge development and function
#831Compositions and method for accurate early pregnancy diagnosis
#832Diagnosis of preeclampsia
#833Treatment and diagnosis of infertitlity using TGFbeta or activin
#834Methods for staining cells for identification and sorting
#835Method for determination of likelihood of occurrence of preterm labor in pregnant females
#836Labor biomarkers, methods comprising same, and methods targeting same
#837Nucleic acids and polypeptides useful for diagnosing complications of pregnancy
#838EPF derived peptides and therapeutic compositions
#839Insulin-like growth factor binding protein-4 protease
#840Compositions and methods for treating female fertility
#841Compositions and methods for determining oocyte development potential
#842Novel method for separation of human sperm from biological samples for application in human identification
#843Adherent entities and uses therefor
#844ADAM12, a novel marker for abnormal cell function
#845Biomarkers for intro-amniotic inflammation
#846Devices for motile sperm separation
#847Marker for inflammatory conditions
#848Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
#849Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion
#850Human cytoplasmic polyadenylation element binding protein and uses thereof
#851Diagnosis of fetal aneuploidy
#852Sperm specific lysozyme-like proteins
#853Use of nuclear hormone receptors
#854Method for detecting and quantitating multiple subcellular components
#855Methods of diagnosing and treating complications of pregnancy
#856Method and apparatus for predicting pregnancy outcome
#857Biological marker for inflammation
#858Inhibin-A: a marker for differentiation, diagnosing and screening abnormal pregnancies
#859Method of diagnosis of pregnancy-related complications
#860Non-invasive prenatal genetic diagnosis using transcervical cells
#861Detection of oncofetal fibronectin for selection of concepti
#862Oncofetal fibronectin as a marker for pregnancy-related indications
#863Oncofetal fibronectin as a marker for health and disease
#864Methods for detecting oncofetal fibronectin
#865Samples for detection of oncofetal fibronectin and uses thereof
#866Quantitative assay with extended dynamic range
#867Point of care diagnostic systems
#868Point of care diagnostic systems
#869Electronic analyte assaying device
#870ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#871Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
#872Real time method of detecting acute inflammatory conditions
#873Methods and compositions for evaluation of fertility
#874Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-gamma
#875Methods for diagnosing labor
#876Antigenic peptides reacting with anti-ovary antibodies
#877Methods and diagnosis for the treatment of preeclampsia
#878Assays
#879Neoepitope detection of disease using protein arrays
#880Proteomic method for predicting success of rescue cerclage
#881Blood cell separating system
#882Determining the estimated date of embryo implantation and related dates
#883Non-invasive prenatal genetic diagnosis using transcervical cells
#884Quantitative lateral flow assays and devices
#885Methods of diagnosing and treating pre-eclampsia or eclampsia
#886Method of analyzing gene expression
#887Compositions and methods for treating female fertility
#888Methods for detecting pregnancy
#889Screening for gestational disorders
#890Screening for gestational disorders
#891Methods and probes for diagnosing a gynaecological condition
#892Marker for inflammatory conditions
#893Diagnostic method for determining the susceptibility to delivery and reagent kit for use thereof
#894Method for diagnosing increased risk of preeclampsia
#895Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
#896Fibronectin variants and screening methods
#897Methods and compositions for evaluation and modulation of fertility
#898Pregnancy-related enzyme activity
#899Compositions and methods for early pregnancy diagnosis
#900Human cytoplasmic polyadenylation element binding protein and uses thereof